Fresenius Se Co Stock Current Liabilities
| FSNUY Stock | USD 8.71 0.05 0.58% |
Fresenius SE Co fundamentals help investors to digest information that contributes to Fresenius' financial success or failures. It also enables traders to predict the movement of Fresenius Pink Sheet. The fundamental analysis module provides a way to measure Fresenius' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Fresenius pink sheet.
Fresenius |
Fresenius SE Co Company Current Liabilities Analysis
Fresenius' Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Fresenius Current Liabilities | 9.5 B |
Most of Fresenius' fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Fresenius SE Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
In accordance with the recently published financial statements, Fresenius SE Co has a Current Liabilities of 9.5 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Medical Care Facilities industry. The current liabilities for all United States stocks is 20.17% lower than that of the firm.
Fresenius Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Fresenius' direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Fresenius could also be used in its relative valuation, which is a method of valuing Fresenius by comparing valuation metrics of similar companies.Fresenius is currently under evaluation in current liabilities category among its peers.
Fresenius Fundamentals
| Return On Equity | 0.0793 | |||
| Return On Asset | 0.0292 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 43.74 B | |||
| Shares Outstanding | 2.25 B | |||
| Price To Earning | 7.33 X | |||
| Price To Book | 0.71 X | |||
| Price To Sales | 0.38 X | |||
| Revenue | 37.52 B | |||
| Gross Profit | 10.26 B | |||
| EBITDA | 2.65 B | |||
| Net Income | 1.82 B | |||
| Cash And Equivalents | 2.13 B | |||
| Cash Per Share | 0.94 X | |||
| Total Debt | 27.16 B | |||
| Debt To Equity | 0.89 % | |||
| Current Ratio | 1.32 X | |||
| Book Value Per Share | 9.49 X | |||
| Cash Flow From Operations | 5.08 B | |||
| Earnings Per Share | 0.77 X | |||
| Price To Earnings To Growth | 1.01 X | |||
| Number Of Employees | 319.69 K | |||
| Beta | 1.08 | |||
| Market Capitalization | 17.65 B | |||
| Total Asset | 71.96 B | |||
| Working Capital | 3.02 B | |||
| Current Asset | 12.51 B | |||
| Current Liabilities | 9.5 B | |||
| Annual Yield | 0.03 % | |||
| Five Year Return | 1.10 % | |||
| Net Asset | 71.96 B | |||
| Last Dividend Paid | 0.92 |
About Fresenius Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Fresenius SE Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fresenius using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fresenius SE Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Fresenius Pink Sheet Analysis
When running Fresenius' price analysis, check to measure Fresenius' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius is operating at the current time. Most of Fresenius' value examination focuses on studying past and present price action to predict the probability of Fresenius' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius' price. Additionally, you may evaluate how the addition of Fresenius to your portfolios can decrease your overall portfolio volatility.